HomeMarketsSharesCME Group Inc.

Trade CME Group Inc. - CME CFD

Market is not available at the momentMarket information is presented
as of 2026-10-08T19:47:17+00:00
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.37
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.022207 %
(-$4.44)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $$19,000.00


-0.02221%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.000015 %
(-$0.00)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $$19,000.00


-0.00002%
Overnight funding adjustment time21:00 (UTC)
CurrencyUSD
Min traded quantity0.1
Margin5.00%
Stock exchangeUnited States of America
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close270.1
Open268.72
1-Year Change1.91%
Day's Range268.72 - 277.54

Trade CME Group Inc. - CME

About CME Group Inc

CME Group Inc. provides products across all asset classes, by trading futures, options, cash and over-the-counter (OTC) products. The Company offers a range of products across interest rates, equity indexes, foreign exchange (FX), agricultural commodities, energy and metals. It also offers cash and repo fixed income trading through BrokerTec, and cash and OTC FX trading through electronic broking services (EBS). The Company’s segment consists of the Chicago Mercantile Exchange Inc. (CME), Board of Trade of the City of Chicago, Inc. (CBOT), New York Mercantile Exchange, Inc. (NYMEX), Commodity Exchange, Inc. (COMEX) and its cash markets business. In addition, it operates central counterparty clearinghouses. The Company offers clearing, settlement and guarantees for all products cleared through the clearinghouse. Its subsidiaries include Astley & Pearce Limited, Board of Trade of the City of Chicago, Inc., BrokerTec Americas LLC, BrokerTec Europe Limited and BrokerTec Holdings Inc.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, CME Group Inc revenues decreased 4% to $4.69B. Net income applicable to common stockholders increased 24% to $2.62B. Revenues reflect Clearing and transaction fees decrease of 3% to $3.77B, Other Revenue - Balancing value decrease of 21% to $337.3M, Rental Income - Gross decrease of 22% to $10.4M. Net income reflects Investment Income increase of 68% to $306.9M (income).

Equity composition

Common Stock Cl. A $.01 Par, 07/11, 1B auth., 66,862,797 issd. Insiders & Strategic holders own 5.7%. IPO: 12/02, 4,751,070 shs. @$35 by Morgan Stanley. Common Stock Cl. B-1 $.01 Par, 3K auth., 625 o/s., Cl. B-2 813 o/s., Cl. B-3 1,287 o/s., Cl.B-4 413 o/s. 07/12, 5-For-1 Stock Split.

Latest shares articles

A GameStop store in Portland, Oregon
GameStop stock forecast: debt exchange, Q2 profit
GameStop is a US video-game retailer. In Q2 fiscal 2026, net sales fell to $790.2m, while operating income rose to $160.2m. Explore third-party GME price targets and technical analysis. Past performance is not a reliable indicator of future results.
14:06, 7 October 2026
Freenet stock forecast
Freenet stock forecast: revenue rises, EBITDA falls
Freenet reported first-half 2026 revenue of €1,512.9 million, up 24.7% year on year, while adjusted EBITDA fell 5.9% to €242.2 million and 2026 guidance was maintained. Explore third-party FNTN price targets and technicals. Past performance is not a reliable indicator of future results.
12:41, 7 October 2026
Hims & Hers Health stock forecast
Hims & Hers Health stock forecast: FDA GLP-1 warning
Hims & Hers Health is a US telehealth company. In August 2026, the FDA issued a warning concerning unapproved compounded GLP-1 weight-loss drugs. Explore third-party HIMS price targets and technical analysis. Past performance is not a reliable indicator of future results.
12:18, 7 October 2026
Arm Holdings stock forecast
Arm Holdings stock forecast: Haas flags AI demand
Arm Holdings is a UK-based semiconductor company. Chief executive Rene Haas said AI and data-centre demand showed no signs of slowing. Explore third-party ARM price targets and technical analysis. Past performance is not a reliable indicator of future results.
09:43, 6 October 2026

User feedback and ratings

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready